CENTERPOINT ADVISORS, LLC Halozyme Therapeutics, Inc. Transaction History

CENTERPOINT ADVISORS, LLC portfolio value:

$42,000
portfolio value

CENTERPOINT ADVISORS, LLC quarter portfolio value change:

-10.14%
quarter

Halozyme Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -4K $39.54 1.05K
Q2 2022 share 0.00% 0 shares 4K $44 1.05K
Q1 2022 share Decrease -4.55% -50 shares -2K $39.88 1.05K
Q4 2021 share 0.00% 0 shares -1K $40.32 1.1K
Q3 2021 share 0.00% 0 shares -5K $40.68 1.1K
Q2 2021 share 0.00% 0 shares 4K $45.41 1.1K
Q1 2021 share 0.00% 0 shares -1K $41.69 1.1K
Q4 2020 share 0.00% 0 shares 18K $42.71 1.1K
Q3 2020 share 0.00% 0 shares 0 $26.28 1.1K
Q2 2020 share 0.00% 0 shares 9K $26.81 1.1K
Q1 2020 share 0.00% 0 shares 0 $17.99 1.1K
Q4 2019 share 0.00% 0 shares 3K $17.73 1.1K
Q3 2019 share 0.00% 0 shares -2K $15.51 1.1K
Q2 2019 share 0.00% 0 shares 1K $17.18 1.1K
Q1 2019 share 0.00% 0 shares 2K $16.1 1.1K
Q4 2018 share 0.00% 0 shares -4K $14.63 1.1K
Q3 2018 share 0.00% 0 shares 1K $18.17 1.1K
Q2 2018 share 0.00% 0 shares -3K $16.87 1.1K
Q1 2018 share 0.00% 0 shares 0 $19.59 1.1K
Q4 2017 share Increase 0.00% 1.1K shares 22K $20.26 1.1K